- Research article
- Open Access
The relation of location-specific epicardial adipose tissue thickness and obstructive coronary artery disease: systemic review and meta-analysis of observational studies
BMC Cardiovascular Disorders volume 14, Article number: 62 (2014)
There is growing evidence about the importance of epicardial adiposity on cardiometabolic risk. However, the relation of location-specific epicardial adipose tissue (EAT) thickness to coronary atherosclerotic burden is still unclear.
This meta-analysis was used to study the relations between location-specific EAT thickness and obstructive coronary artery disease (CAD). A systemic literature search to identify eligible studies that met the inclusion criteria from the beginning until January 2014 was made. We conducted the meta-analysis of all included 10 published studies. Pre-specified subgroup analyses were performed according to ethnicity, body mass index, diagnostic tools for CAD, and measurement tool if presence of high heterogeneity between studies. Potential publication bias was also assessed.
We identified ten observed studies with a total of 1625 subjects for planned comparison. With regard to the association between obstructive CAD and location-specific EAT thickness at the right ventricular free wall, caution is warranted. The pooled estimate showed that location-specific EAT thickness at the right ventricular free wall was significantly higher in the CAD group than non-CAD group (standardized mean difference (SMD): 0.70 mm, 95% CI: 0.26-1.13, P = 0.002), although heterogeneity was high (I2 = 93%). It should be clear that only the result of echocardiography-based studies showed a significant association (SMD: 0.98 mm, 95% CI: 0.43-1.53, P = 0.0005), and the result of all included CT-based studies showed a non-significant association (SMD: 0.06 mm, 95% CI: -0.12-0.25, P = 0.50). In the subgroup analysis, the “diagnostic tools for CAD” or “measurement tool of EAT thickness” are potential major sources of heterogeneity between studies. With regard to location-specific EAT thickness at the left atrioventricular (AV) groove, it was significantly higher in the CAD group than non-CAD group (SMD: 0.74 mm, 95% CI: 0.55-0.92, P <0.00001; I2 = 0%).
Our meta-analysis suggests that significantly elevated location-specific EAT thickness at the left AV groove is associated with obstructive CAD. Based on the current evidence, the location-specific EAT thickness at the left AV groove appears to be a good predictor in obstructive CAD, especially in Asian populations. Furthermore well-designed studies are warranted because of the current limited number of studies.
Excessive epicardial adipose tissue (EAT) accumulation within the pericardial sac has been suggested to play an important role in the development of coronary artery atherosclerosis through potential paracrine or endocrine mechanism by exerting inflammatory mediators such as TNF-alpha, IL-6, adipocytokines, and leptin [1–5]. Several previous studies have found that CT-measured EAT volume played an important causal role in coronary atherosclerotic burden or coronary artery disease [6–8].
There is increasing attention on the location-specific EAT thickness as a potential predictor in cardiometabolic disease because of uneven regional distribution of EAT around the heart, especially mostly located in the atrioventricular (AV) groove and interventricular (IV) groove [9–11]. Echocardiographic EAT measurement is a non-invasive and simple way to measure location-specific EAT at the right ventricular free wall clinically [12–17]. Alternatively, CT (computed tomography) or MRI (magnetic resonance imaging) can also provide the simple but precise 2D measurement in the thickness of EAT in all cardiac segments [11, 18, 19]. Current evidence about the association between location-specific EAT thickness at the right ventricular free wall and coronary artery disease (CAD) is still controversial. Several studies using echocardiography have demonstrated a significant relationship between CAD and location-specific EAT thickness measured at right ventricular free wall [13, 14, 16, 17], while some studies using echocardiography or CT failed to observe a significant association [11, 12, 19, 20]. Recent evidence has suggested that there is increasing attention on location-specific EAT thickness at the left AV groove as a potentially new biomarker associated with cardiometabolic risks by using 2D CT or MR measurement [11, 19, 21, 22]. In this study, we conducted a meta-analysis to study the relationship between location-specific EAT thickness and obstructive CAD, which may serve as a reliable predictor and improve CAD risk stratification in the future.
This meta-analysis was conducted according to the Meta-analysis Of Observational Studies in Epidemiology (MOOSE) statement .
We searched the Pubmed, Ovid Medline, Ovid Embase and Cochrane databases for relevant articles. Reviews were independently performed by two authors using the following search terms: “epicardial adipose tissue”, “epicardial fat”, “subepicardial adipose tissue”, “subepicardial fat”, “coronary artery disease [Mesh]”, “atherosclerosis [Mesh]”, and “cardiovascular disease [Mesh]”, from the beginning of publication until January 2014. No language restrictions were applied. The pre-specified inclusion criteria were as follows: (a) observational studies to investigate the relationship between location-specific EAT thickness and CAD measured by echocardiography, CT or MRI-based quantitative measurements; (b) subjects with suspicion of CAD or at high risk of CAD clinically, and then subsequently divided into CAD and non-CAD groups assessed by coronary angiography, coronary CT angiography and coronary MR angiography. CAD group was defined as luminal stenosis ≥ 50% in one or more coronary arteries; and (c) for each study, the mean difference, standard deviation (SD) and sample size of subjects of CAD and non-CAD groups were reported in the literature. References within studies that met the inclusion criteria were reviewed for any possible missing relevant articles. Studies were excluded if any of the inclusion criteria were not met. All 10 published studies that met these inclusion criteria were considered eligible for further meta-analysis.
Data extraction and quality assessment
Data were abstracted and quality of studies was assessed independently by two reviewers (F.Z.W. and M.T.W.). Disagreement on specific studies between the two reviewers was resolved by consensus. Data were extracted from each study including the sample size and mean difference ± SD in location-specific EAT thickness in both CAD and non-CAD groups (regrouping and calculating the mean difference and mixed SD in the study of Eroglu et al. ). Methodological study quality was assessed using the Strengthening of Reporting of Observational Studies in Epidemiology (STROBE) checklist of 22 items .
All statistical analyses were performed using the Comprehensive Meta-Analysis version 2 (Biostat, Englewood, New Jersey) and the Review Manager 5.0 software, available through the Cochrane Collaboration. Both fixed- and random-effects models were used for analysis of the standardized mean difference (SMD) in the CAD and non-CAD group. Heterogeneity was assessed and quantified using Cochran’s Q statistic and the I2 statistic . If I2 was below 30%, fixed effects were chosen; if I2 was equal to or greater than 30%, then random effects were applied . Before the analysis, we formed a prior hypothesis that if heterogeneity existed in the studies, the source could be due to: (1) diagnostic tool for CAD (coronary angiography vs. coronary CT angiography); (2) ethnicity (Asian vs. non-Asian); (3) measurement tool of EAT (echocardiography vs. CT); and (4) body mass index (BMI). We also performed subgroup and univariate meta-regression analyses to investigate potential sources of variability. Publication bias was assessed if available by using Egger’s test to examine the likely presence of publication bias.
Study identification and selection
Overall, 312 articles were initially identified according to the broad criteria. After the initial screening of the title and abstract, 21 potentially relevant articles were retrieved for detailed review of their full text. Many studies that investigated the association between epicardial fat volume and CAD were excluded in this step.
In all these relevant studies, 11 studies were excluded after the detail review of their full text. Of these 11 studies, five studies were excluded because they did not report the detailed data for the meta-analysis [27–31]; two studies were excluded because of an investigation of the relationship between the EAT volume or area with CAD [32, 33]; two studies were excluded because the study subjects were not well-defined or did not meet the criteria [15, 34]; and the remaining two were letters and experimental studies [5, 35]. The remaining 10 observational studies were eligible for the meta-analysis [11–14, 16, 17, 19–21, 36]. The flowchart of the search and selection of studies in this meta-analysis is illustrated in Figure 1. Overall, these studies included 1625 patients (924 subjects with CAD, and 701 subjects without CAD).
Table 1 summarize the characteristics of the nine observational studies investigating the association between location-specific EAT thickness at the right ventricular free wall and obstructive CAD. Table 2 summarizes the characteristics of the three observational studies investigating the association between location-specific EAT thickness at the left AV groove and obstructive CAD.
Location-specific EAT thickness at the right ventricular free wall and obstructive CAD
With regard to the association between the location-specific EAT thickness at the right ventricular free wall and obstructive CAD, there was a significant difference in the SMD between CAD and no-CAD groups (0.70 mm, 95% CI: 0.26-1.13, p = 0.002) in a random-effect pooled analysis of these studies (fixed-effect model in the Additional file 1: Figure S1). Statistically significant heterogeneity was observed in the study results (p < 0.00001, I2 = 93%). There was no indication of publication bias with Egger’s test (p = 0.229, funnel plot shown in Additional file 2: Figure S2). A sensitivity analysis, in which one study was removed at a time, was performed to evaluate the stability of the results. Results were similar in all sensitivity analyses.
Subgroup analyses were performed in an attempt to explore the possible causes of heterogeneity, according to ethnicity, diagnostic tools for CAD, and measurement tool of EAT thickness. In subgroup analysis according to ethnicity shown in Table 3, the test for subgroup differences did not show a significant interaction. In contrast, the test for subgroup differences showed a significant interaction in the subgroup analysis according to diagnostic tools for CAD. In addition, the test for subgroup differences showed a significant interaction according to measurement tool of EAT thickness. In the subgroup of echocardiography-based studies, the random-effects model was used for the analysis, because the test for heterogeneity was statistically significant (p < 0.00001; I2 = 94%). There was a significant difference in the SMD between CAD and no-CAD groups (0.98 mm, 95% CI: 0.43-1.53, p = 0.0005). By contrast, there was no significant difference in the SMD between CAD and no-CAD groups (0.06 mm, 95% CI: -0.12-0.25, p = 0.50) in the subgroup of CT-based studies, and greater homogeneity was also observed within this subgroup shown in Figure 2 (p = 0.43; I2 = 0). Therefore, diagnostic tools for CAD and measurement tool of EAT thickness were the potential sources of heterogeneity between studies. In univariate random effects meta-regression analysis, BMI was not significantly associated with effect size shown in Figure 3 (95% CI: -0.24 -0.17, p = 0.59).
Location-specific EAT thickness at the left AV groove and obstructive CAD
Figure 4 shows the forest plot of the pooled results of the SMD of the three studies in order to investigation the association between obstructive CAD and EAT thickness at the left AV groove. In a fixed-effect pooled analysis, there was a significant difference in the SMD between CAD and no-CAD groups (0.74 mm, 95% CI: 0.55-0.92, p < 0.00001), and low heterogeneity among the three studies shown in Figure 4 (p = 0.61, I2 = 0%). Overall, location-specific EAT thickness at the left AV groove was significantly thicker in the CAD group than the no-CAD group. Publication bias was not assessed because of limited studies.
The role of location-specific EAT thickness at the right ventricular free wall in obstructive CAD
With regard to the association between the location-specific EAT thickness at the right ventricular free wall and obstructive CAD, the overall results of the meta-analysis in nine studies show a statistically significantly increase in EAT thickness at the right ventricular free wall in the CAD group than in the no-CAD group.
It should be clear that only the result of echocardiography-based studies (six studies) showed a significant association between CAD and the EAT thickness at right ventricular free wall, and the result of all included CT-based studies (three studies) showed a non-significant association. And low between-study heterogeneity was also observed in the CT-based studies (three studies) assessed at the right ventricular free wall. However, extreme between-study heterogeneity was also observed in the overall meta-analysis (nine studies) and echocardiography-based studies (six studies). Therefore, all this evidence suggested that CT-based measurement may potentially be a more reliable tool than echocardiography-based measurement.
Regarding the association between location-specific EAT thickness at the right ventricular free wall and obstructive CAD, subgroup and meta-regression analyses for all covariates have been used to address the issues of heterogeneity between studies. A recent meta-analysis of worldwide study demonstrates a significant correlation between EAT and BMI, but shows a relationship between EAT and metabolic syndrome independent of BMI . These findings support the meta-regression analysis in our study that revealed BMI was not considered a potential source of heterogeneity between eight studies.
We think a possible explanation for the high heterogeneity between studies was that the difference in reliability and reproducibility between the two tools (echocardiography vs. CT) should be seriously concerned. In comparison with CT-based measurement, echocardiography is a non-invasive imaging modality in EAT measurement that requires less cost and is less time-consuming. However, a recent study has shown the poor reproducibility of echocardiographic EAT measurements assessed by intraclass correlation coefficient, and low concordance observed between CT and echocardiographic measurement . One the contrary, several studies have demonstrated high interobserver reliability and intraobserver reproducibility of EAT thickness measured by CT [11, 39, 40]. Potential measurement bias in the EAT measurement by echocardiography may contribute to the disparate results between echocardiography-based and CT-based studies. And recent longitudinal studies have also demonstrated non-association between EAT thickness assessed by echocardiography and cardiac events or major adverse cardiac events (MACE) [29, 31], which also supports the negative result by CT-based studies in the subgroup analysis. Therefore, we suggest that the effect of location-specific EAT at the right ventricular free wall on CAD is still uncertain. However, future well-designed studies are warranted because of limited CT-based studies measuring location-specific EAT thickness at the right ventricular free wall.
The role of location-specific EAT thickness at the left AV groove in obstructive CAD
With regard to the association between the location-specific EAT thickness at the left AV groove and obstructive CAD, the results from the current meta-analysis indicate increased location-specific EAT thickness at the left AV groove was associated with obstructive CAD assessed by CT or MRI.
And high homogeneity between studies was observed, despite diagnosis of CAD in different imaging modalities, including coronary angiography, coronary CT angiography and MR coronary angiography. Substantial evidence has also supported the diagnostic accuracy of coronary CT angiography and MR coronary angiography in the evaluation of coronary arteries stenosis [41–43].
While there is no obvious explanation for this observation, uneven regional distribution of EAT around the heart may provide clues. Recent studies also suggest that location-specific EAT thickness at the left AV groove may play a important causal role in cardiometabolic disease through a possible mechanism described by Wang et al.  whereby diffusion of EAT paracrine metabolites through thin-walled coronary venous networks into the coronary sinus is due to abundant coronary venous sinus drainage networks in the left AV groove. In addition, location-specific EAT thickness at the left AV groove can be easily and reliably assessed in 2D-based CT or MRI images available in routine clinical practice for cardiovascular risk assessment [11, 19, 21]. Taken together, these findings may indicate that combined measurement of EAT thickness in the left AV groove and coronary calcium score provides more in-depth information than conventional risk factor assessment in CAD prediction . Because of the limited number of studies almost exclusively in Asian populations, future well-designed cohort studies are warranted to investigate the cause-effect relationship by CT or MRI.
Study strengths and limitations
It is our belief that the present study has demonstrated certain advantages over the previous meta-analysis . First, in contrast to previous meta-analysis by Xu et al.  on this topic, we used explicit criteria to define inclusion criteria. To investigate the association between regional EAT thickness and CAD, we select the location-specific EAT thickness at the right ventricular free wall or left AV groove by echocardiography, CT or MRI rigorously. However, the previous meta-analysis has used these data of the “average” EAT thickness extracted from the study by Wang et al. . Second, the aims of the previous meta-analysis and our study were both to investigate the relationship between EAT thickness and CAD. We found one included study in the previous meta-analysis that investigated the relationship between regional EAT thickness and descending thoracic aorta atherosclerosis , instead of all included nine studies rigorously assessing obstructive CAD in our study. Third, study quality was assessed using the STROBE statement to ensure that all studies reach a level of quality in this meta-analyses.
The current study had several potential limitations. First, all ten included studies in the present meta-analysis were case-control or cross-sectional studies despite assessing study quality using the STROBE statement, which has limitations in providing definite information about the cause-and-effect relationship. In addition, the best evidence comes primarily from meta-analyses of randomized controlled trials. Second, there are many confounding factors associated with CAD, such as the Framingham risk score and CAC score were not considered in this meta-analyses. However, we have investigated a number of factors to explore between-study heterogeneity. The included studies were different in diagnostic tools for CAD and measurement tools of EAT, which may contribute to the heterogeneity among the studies. Third, there are limited studies in assessing the association between left AVG EAT thickness and obstructive CAD despite recognition that homogeneity exists between studies, which may lead to insufficient evidence to support the result.
In summary, our meta-analysis suggests that significantly elevated location-specific EAT thickness at the left AV groove is associated with obstructive CAD, and homogeneity influenced agreement between studies. Based on the current evidence, the location-specific EAT thickness at the left AV groove appears to play an influential role in the prediction of obstructive CAD, especially in Asian populations. In addition, adding EAT thickness at the left AV groove on top of clinical CAD risk factors plus Agatston score may provide further evidence in predicting CAD in the population with suspicion of CAD [19, 44]. Subsequent, large, more definitive studies are needed to confirm these findings and to establish if location-specific EAT thickness at the left AV groove be used in clinical context.
Body mass index
Coronary arterial calcification
Coronary artery disease
Epicardial adipose tissue
Magnetic resonance imaging
- MOOSE statement:
Meta-analysis Of Observational Studies in Epidemiology statement
Standardized mean difference
- STROBE checklist:
Strengthening of Reporting of Observational Studies in Epidemiology checklist
Major adverse cardiac events.
Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, Sarov-Blat L, O’Brien S, Keiper EA, Johnson AG, Martin J, Goldstein BJ, Shi Y: Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003, 108 (20): 2460-2466. 10.1161/01.CIR.0000099542.57313.C5.
Baker A, da Silva N, Quinn D, Harte A, Pagano D, Bonser R, Kumar S, McTernan P: Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol. 2006, 5 (1): 1-7. 10.1186/1475-2840-5-1.
Sacks HS, Fain JN: Human epicardial adipose tissue: a review. Am Heart J. 2007, 153 (6): 907-917. 10.1016/j.ahj.2007.03.019.
Iacobellis G, Corradi D, Sharma AM: Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med. 2005, 2 (10): 536-543. 10.1038/ncpcardio0319.
Iacobellis G, Pistilli D, Gucciardo M, Leonetti F, Miraldi F, Brancaccio G, Gallo P, di Gioia CR: Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine. 2005, 29 (6): 251-255.
Iwasaki K, Matsumoto T, Aono H, Furukawa H, Samukawa M: Relationship between epicardial fat measured by 64-multidetector computed tomography and coronary artery disease. Clin Cardiol. 2011, 34 (3): 166-171. 10.1002/clc.20840.
Rosito GA, Massaro JM, Hoffmann U, Ruberg FL, Mahabadi AA, Vasan RS, O'Donnell CJ, Fox CS: Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation. 2008, 117 (5): 605-613. 10.1161/CIRCULATIONAHA.107.743062.
Ahmadi N, Nabavi V, Yang E, Hajsadeghi F, Lakis M, Flores F, Zeb I, Bevinal M, Ebrahimi R, Budoff M: Increased epicardial, pericardial, and subcutaneous adipose tissue is associated with the presence and severity of coronary artery calcium. Acad Radiol. 2010, 17 (12): 1518-1524. 10.1016/j.acra.2010.08.017.
Gorter PM, de Vos AM, van der Graaf Y, Stella PR, Doevendans PA, Meijs MF, Prokop M, Visseren FL: Relation of epicardial and pericoronary fat to coronary atherosclerosis and coronary artery calcium in patients undergoing coronary angiography. Am J Cardiol. 2008, 102 (4): 380-385. 10.1016/j.amjcard.2008.04.002.
de Vos AM, Prokop M, Roos CJ, Meijs MF, van der Schouw YT, Rutten A, Gorter PM, Cramer MJ, Doevendans PA, Rensing BJ, Bartelink ML, Velthuis BK, Mosterd A, Bots ML: Peri-coronary epicardial adipose tissue is related to cardiovascular risk factors and coronary artery calcification in post-menopausal women. Eur Heart J. 2008, 29 (6): 777-783. 10.1093/eurheartj/ehm564.
Wang TD, Lee WJ, Shih FY, Huang CH, Chen WJ, Lee YT, Shih TT, Chen MF: Association of epicardial adipose tissue with coronary atherosclerosis is region-specific and independent of conventional risk factors and intra-abdominal adiposity. Atherosclerosis. 2010, 213 (1): 279-287. 10.1016/j.atherosclerosis.2010.07.055.
Chaowalit N, Somers VK, Pellikka PA, Rihal CS, Lopez-Jimenez F: Subepicardial adipose tissue and the presence and severity of coronary artery disease. Atherosclerosis. 2006, 186 (2): 354-359. 10.1016/j.atherosclerosis.2005.08.004.
Yun KH, Rhee SJ, Yoo NJ, Oh SK, Kim NH, Jeong JW, Park DS, Park HY: Relationship between the Echocardiographic Epicardial Adipose Tissue Thickness and Serum Adiponectin in Patients with Angina. J Cardiovasc Ultrasound. 2009, 17 (4): 121-126. 10.4250/jcu.2009.17.4.121.
Eroglu S, Sade LE, Yildirir A, Bal U, Ozbicer S, Ozgul AS, Bozbas H, Aydinalp A, Muderrisoglu H: Epicardial adipose tissue thickness by echocardiography is a marker for the presence and severity of coronary artery disease. Nutr Metab Cardiovasc Dis. 2009, 19 (3): 211-217. 10.1016/j.numecd.2008.05.002.
Iacobellis G, Lonn E, Lamy A, Singh N, Sharma AM: Epicardial fat thickness and coronary artery disease correlate independently of obesity. Int J Cardiol. 2011, 146 (3): 452-454. 10.1016/j.ijcard.2010.10.117.
Mustelier JV, Rego JOC, González AG, Sarmiento JCG, Riverón BV: Parâmetros ecocardiográficos de deposição de gordura epicárdica e sua relação com doença arterial coronariana. Arq Bras Cardiol. 2011, 97: 122-129. 10.1590/S0066-782X2011005000068.
Shemirani H, Khoshavi M: Correlation of echocardiographic epicardial fat thickness with severity of coronary artery disease-an observational study. Anadolu Kardiyol Derg. 2012, 12 (3): 200-205.
Liang KW, Tsai IC, Lee WJ, Lee IT, Lee WL, Lin SY, Wan CJ, Fu CP, Ting CT, Sheu WH: MRI measured epicardial adipose tissue thickness at the right AV groove differentiates inflammatory status in obese men with metabolic syndrome. Obesity (Silver Spring). 2012, 20 (3): 525-532. 10.1038/oby.2011.155.
Wu FZ, Huang YL, Wang YC, Lin HS, Chen CS, Ju YJ, Chiou KR, Cheng CC, Wu MT: Impact of location of epicardial adipose tissue, measured by coronary artery calcium-scoring computed tomography on obstructive coronary artery disease. Am J Cardiol. 2013, 112 (7): 943-949. 10.1016/j.amjcard.2013.05.022.
Bastarrika G, Broncano J, Schoepf UJ, Schwarz F, Lee YS, Abro JA, Costello P, Zwerner PL: Relationship between coronary artery disease and epicardial adipose tissue quantification at cardiac CT: comparison between automatic volumetric measurement and manual bidimensional estimation. Acad Radiol. 2010, 17 (6): 727-734. 10.1016/j.acra.2010.01.015.
Kim HM, Kim KJ, Lee HJ, Yu HT, Moon JH, Kang ES, Cha BS, Lee HC, Lee BW, Kim YJ: Epicardial adipose tissue thickness is an indicator for coronary artery stenosis in asymptomatic type 2 diabetic patients: its assessment by cardiac magnetic resonance. Cardiovasc Diabetol. 2012, 11: 83-10.1186/1475-2840-11-83.
Wang TD, Lee WJ, Shih FY, Huang CH, Chang YC, Chen WJ, Lee YT, Chen MF: Relations of epicardial adipose tissue measured by multidetector computed tomography to components of the metabolic syndrome are region-specific and independent of anthropometric indexes and intraabdominal visceral fat. J Clin Endocrinol Metab. 2009, 94 (2): 662-669. 10.1210/jc.2008-0834.
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB: Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000, 283 (15): 2008-2012. 10.1001/jama.283.15.2008.
von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007, 4 (10): e296-10.1371/journal.pmed.0040296.
Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ. 2003, 327 (7414): 557-560. 10.1136/bmj.327.7414.557.
DerSimonian R, Kacker R: Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials. 2007, 28 (2): 105-114. 10.1016/j.cct.2006.04.004.
Ahn SG, Lim HS, Joe DY, Kang SJ, Choi BJ, Choi SY, Yoon MH, Hwang GS, Tahk SJ, Shin JH: Relationship of epicardial adipose tissue by echocardiography to coronary artery disease. Heart. 2008, 94 (3): e7-10.1136/hrt.2007.118471.
Jeong JW, Jeong MH, Yun KH, Oh SK, Park EM, Kim YK, Rhee SJ, Lee EM, Lee J, Yoo NJ, Kim NH, Park JC: Echocardiographic epicardial fat thickness and coronary artery disease. Circ J. 2007, 71 (4): 536-539. 10.1253/circj.71.536.
Kaushik M, Saurav A, Smer A, Alla VM, Khan S, Madan R, Holmberg MJ, Mohiuddin S: Epicardial adipose tissue as assessed by echocardiography and incident cardiac disease. J Am Coll Cardiol. 2012, 59 (13s1): E1159-
Nelson MR, Mookadam F, Thota V, Emani U, Al Harthi M, Lester SJ, Cha S, Stepanek J, Hurst RT: Epicardial fat: an additional measurement for subclinical atherosclerosis and cardiovascular risk stratification?. J Am Soc Echocardiogr. 2011, 24 (3): 339-345. 10.1016/j.echo.2010.11.008.
Albuquerque FN, Somers VK, Blume G, Miranda W, Korenfeld Y, Calvin AD, Qin R, Lopez-Jimenez F: Usefulness of epicardial adipose tissue as predictor of cardiovascular events in patients with coronary artery disease. Am J Cardiol. 2012, 110 (8): 1100-1105. 10.1016/j.amjcard.2012.06.003.
Bettencourt N, Toschke AM, Leite D, Rocha J, Carvalho M, Sampaio F, Xara S, Leite-Moreira A, Nagel E, Gama V: Epicardial adipose tissue is an independent predictor of coronary atherosclerotic burden. Int J Cardiol. 2012, 158 (1): 26-32. 10.1016/j.ijcard.2010.12.085.
Sironi AM, Petz R, De Marchi D, Buzzigoli E, Ciociaro D, Positano V, Lombardi M, Ferrannini E, Gastaldelli A: Impact of increased visceral and cardiac fat on cardiometabolic risk and disease. Diabet Med. 2012, 29 (5): 622-627. 10.1111/j.1464-5491.2011.03503.x.
Bachar GN, Dicker D, Kornowski R, Atar E: Epicardial adipose tissue as a predictor of coronary artery disease in asymptomatic subjects. Am J Cardiol. 2012, 110 (4): 534-538. 10.1016/j.amjcard.2012.04.024.
Cabrera-Rego JO: Echocardiographic measurement of epicardial fat thickness: in search for a consensus/Correlation of echocardiographic epicardial fat thickness with severity of coronary artery disease-an observational study. Anadolu Kardiyol Derg. 2012, 12 (5): 448-449. author reply 449
Kaya H, Ertas F, Oylumlu M, Bilik MZ, Yildiz A, Yuksel M, Polat N, Acet H, Isik F, Ulgen MS: Relation of epicardial fat thickness and brachial flow-mediated vasodilation with coronary artery disease. J Cardiol. 2013, 62 (6): 343-347. 10.1016/j.jjcc.2013.05.009.
Rabkin SW: The relationship between epicardial fat and indices of obesity and the metabolic syndrome: a systematic review and meta-analysis. Metab Syndr Relat Disord. 2014, 12 (1): 31-42. 10.1089/met.2013.0107.
Saura D, Oliva MJ, Rodriguez D, Pascual-Figal DA, Hurtado JA, Pinar E, de la Morena G, Valdes M: Reproducibility of echocardiographic measurements of epicardial fat thickness. Int J Cardiol. 2010, 141 (3): 311-313. 10.1016/j.ijcard.2008.11.127.
Abbara S, Desai JC, Cury RC, Butler J, Nieman K, Reddy V: Mapping epicardial fat with multi-detector computed tomography to facilitate percutaneous transepicardial arrhythmia ablation. Eur J Radiol. 2006, 57 (3): 417-422. 10.1016/j.ejrad.2005.12.030.
Gorter PM, van Lindert AS, de Vos AM, Meijs MF, van der Graaf Y, Doevendans PA, Prokop M, Visseren FL: Quantification of epicardial and peri-coronary fat using cardiac computed tomography; reproducibility and relation with obesity and metabolic syndrome in patients suspected of coronary artery disease. Atherosclerosis. 2008, 197 (2): 896-903. 10.1016/j.atherosclerosis.2007.08.016.
Yonezawa M, Nagata M, Kitagawa K, Kato S, Yoon Y, Nakajima H, Nakamori S, Sakuma H, Hatakenaka M, Honda H: Quantitative analysis of 1.5-T whole-heart coronary MR angiograms obtained with 32-channel cardiac coils: a comparison with conventional quantitative coronary angiography. Radiology. 2014, 271 (2): 356-364. 10.1148/radiol.13122491.
Meijboom WB, Meijs MF, Schuijf JD, Cramer MJ, Mollet NR, van Mieghem CA, Nieman K, van Werkhoven JM, Pundziute G, Weustink AC, de Vos AM, Pugliese F, Rensing B, Jukema JW, Bax JJ, Prokop M, Doevendans PA, Hunink MG, Krestin GP, de Feyter PJ: Diagnostic accuracy of 64-slice computed tomography coronary angiography: a prospective, multicenter, multivendor study. J Am Coll Cardiol. 2008, 52 (25): 2135-2144. 10.1016/j.jacc.2008.08.058.
Budoff MJ, Dowe D, Jollis JG, Gitter M, Sutherland J, Halamert E, Scherer M, Bellinger R, Martin A, Benton R, Delago A, Min JK: Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial. J Am Coll Cardiol. 2008, 52 (21): 1724-1732. 10.1016/j.jacc.2008.07.031.
Canpolat U, Ozcan F, Ozeke O, Turak O, Aydogdu S: Usefulness of screening left atrioventricular groove epicardial adipose tissue thickness. Am J Cardiol. 2013, 112 (7): 1054-1055. 10.1016/j.amjcard.2013.07.032.
Xu Y, Cheng X, Hong K, Huang C, Wan L: How to interpret epicardial adipose tissue as a cause of coronary artery disease: a meta-analysis. Coron Artery Dis. 2012, 23 (4): 227-233. 10.1097/MCA.0b013e328351ab2c.
Yorgun H, Canpolat U, Hazirolan T, Sunman H, Ates AH, Gurses KM, Ertugrul O, Kaya EB, Aytemir K, Tokgozoglu L, Kabakci G, Oto A: Epicardial adipose tissue thickness predicts descending thoracic aorta atherosclerosis shown by multidetector computed tomography. Int J Cardiovasc Imaging. 2012, 28 (4): 911-919. 10.1007/s10554-011-9899-x.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2261/14/62/prepub
We are grateful to Dr. Carol C. Wu for reviewing the manuscript. This study was supported by Grants from National Science Council NSC97-2314-B-010-045-MY3 and Kaohsiung Veterans General Hospital, VGHKS101-020, VGHKS100-074, Taiwan, R.O.C.
The authors declare that they have no competing interests.
FZW and MTW participated in the conception, design of the study, collected the data, performed statistical analyses, and drafted the manuscript. YLH and KJC helped to collect data and draft the manuscript. All authors read and approved the final manuscript.
Electronic supplementary material
Additional file 1: Figure S1: Forest plot for SMD (fixed-effect model) in location-specific EAT thickness at the right ventricular free wall between CAD and non-CAD groups in the overall meta-analysis (including nine published studies). Moreover, subgroup analyses were assessed by the measurement tool of EAT thickness (echocardiography or CT). SMD, standardized mean difference; CAD, coronary artery disease; EAT, epicardial adipose tissue. (TIFF 196 KB)
Additional file 2: Figure S2: Funnel plot for potential publication bias in the overall meta-analysis of the association between location-specific EAT at the right ventricular free wall and obstructive CAD, including nine studies. EAT, epicardial adipose tissue; CAD, coronary artery disease. (JPEG 69 KB)
About this article
Cite this article
Wu, FZ., Chou, KJ., Huang, YL. et al. The relation of location-specific epicardial adipose tissue thickness and obstructive coronary artery disease: systemic review and meta-analysis of observational studies. BMC Cardiovasc Disord 14, 62 (2014). https://doi.org/10.1186/1471-2261-14-62
- Coronary artery disease
- Location-specific epicardial adipose tissue thickness